Project CIT003 – COT003-01 Phase III DBRMC Controlled study to evaluate efficacy an safety of intravenous L-citrulline…

Basic data

Acronym:
CIT003
Title:
COT003-01 Phase III DBRMC Controlled study to evaluate efficacy an safety of intravenous L-citrulline for the prevention of clinical sequelae of ALI inuced by CPB
Duration:
23/10/2017 to 31/12/2022
Abstract / short description:
CIT003-01
A Phase III Double blind randomized muli center Controlled study to evaluate efficacy an safety of intravenous L-citrulline for the prevention of clinical sequelae of ALI inuced by CPB undergoing surgery for congenital heart defects

Involved staff

Managers

Faculty of Medicine
University of Tübingen
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen

Local organizational units

Paediatrics Department II and Polyclinic
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine

Funders

Baltimore, Maryland, United States of America
Help

will be deleted permanently. This cannot be undone.